NO20050506L - Fast dispersjon inneholdende to ulike polymermatrikser - Google Patents
Fast dispersjon inneholdende to ulike polymermatrikserInfo
- Publication number
- NO20050506L NO20050506L NO20050506A NO20050506A NO20050506L NO 20050506 L NO20050506 L NO 20050506L NO 20050506 A NO20050506 A NO 20050506A NO 20050506 A NO20050506 A NO 20050506A NO 20050506 L NO20050506 L NO 20050506L
- Authority
- NO
- Norway
- Prior art keywords
- solid dispersion
- dispersion containing
- different polymer
- polymer matrices
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP0207422 | 2002-07-04 | ||
| PCT/EP2003/006999 WO2004004683A1 (en) | 2002-07-04 | 2003-07-01 | Solid dispersions comprising two different polymer matrixes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20050506L true NO20050506L (no) | 2005-01-28 |
Family
ID=30011034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20050506A NO20050506L (no) | 2002-07-04 | 2005-01-28 | Fast dispersjon inneholdende to ulike polymermatrikser |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7407670B2 (ja) |
| EP (1) | EP1521571A1 (ja) |
| JP (1) | JP2005538973A (ja) |
| CN (1) | CN1318019C (ja) |
| AU (1) | AU2003246351B2 (ja) |
| CA (1) | CA2489071A1 (ja) |
| HK (1) | HK1080373A1 (ja) |
| NO (1) | NO20050506L (ja) |
| NZ (1) | NZ536975A (ja) |
| WO (1) | WO2004004683A1 (ja) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
| US7927703B2 (en) * | 2003-04-11 | 2011-04-19 | 3M Innovative Properties Company | Adhesive blends, articles, and methods |
| US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
| US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
| CN1997372B (zh) | 2004-06-24 | 2010-06-02 | 西梯茜生命工学股份有限公司 | 包含依他康那唑的固态分散剂的制造方法及其医药组成物 |
| US20100172989A1 (en) * | 2006-01-21 | 2010-07-08 | Abbott Laboratories | Abuse resistant melt extruded formulation having reduced alcohol interaction |
| US20090022798A1 (en) * | 2007-07-20 | 2009-01-22 | Abbott Gmbh & Co. Kg | Formulations of nonopioid and confined opioid analgesics |
| US20090317355A1 (en) * | 2006-01-21 | 2009-12-24 | Abbott Gmbh & Co. Kg, | Abuse resistant melt extruded formulation having reduced alcohol interaction |
| US7872560B2 (en) * | 2007-03-19 | 2011-01-18 | Abc Taiwan Electronics Corp. | Independent planar transformer |
| SI2200588T1 (sl) * | 2007-09-25 | 2019-08-30 | Solubest Ltd. | Sestavki, ki obsegajo lipofilne aktivne spojine, in postopek za njihovo pripravo |
| US9226907B2 (en) | 2008-02-01 | 2016-01-05 | Abbvie Inc. | Extended release hydrocodone acetaminophen and related methods and uses thereof |
| EP2105130A1 (de) * | 2008-03-25 | 2009-09-30 | Ratiopharm GmbH | Pharmazeutische Formulierung und Verfahren zu deren Herstellung |
| EP2133068A1 (de) * | 2008-06-13 | 2009-12-16 | Ratiopharm GmbH | Verfahren zur Auswahl eines geeigneten Hilfsstoffs für die Herstellung von festen Dispersionen für pharmazeutische Formulierungen |
| CA2798884C (en) | 2010-05-10 | 2016-09-13 | Euro-Celtique S.A. | Manufacturing of active-free granules and tablets comprising the same |
| US9901540B2 (en) | 2010-05-10 | 2018-02-27 | Euro-Celtique S.A. | Combination of active loaded granules with additional actives |
| SE1251371A1 (sv) | 2010-05-10 | 2012-12-27 | Euro Celtique Sa | Farmaceutiska kompositioner innefattande hydromorfon och naloxon |
| CN103249457A (zh) | 2010-12-13 | 2013-08-14 | 高露洁-棕榄公司 | 口腔组合物及其制备方法 |
| RU2013139701A (ru) | 2011-02-17 | 2015-03-27 | Ф. Хоффманн-Ля Рош Аг | Способ контролируемой кристаллизации активного фармацевтического ингредиента из состояния переохлажденной жидкости экструзией горячего распада |
| WO2012129072A1 (en) | 2011-03-18 | 2012-09-27 | Particle Dynamics International, Llc | Solid particulate compositions comprising coenzyme q10 |
| AU2012291631A1 (en) | 2011-08-01 | 2014-02-27 | Sun Pharmaceutical Industries Limited | Dissolution enhanced controlled drug delivery system for poorly water soluble drugs |
| WO2013030789A1 (en) | 2011-08-30 | 2013-03-07 | Ranbaxy Laboratories Limited | Pharmaceutical oral solid dosage form containing a poorly water soluble pde - iv inhibitor |
| US8791045B2 (en) | 2011-11-09 | 2014-07-29 | Kimberly-Clark Worldwide, Inc. | Non-tacky wetness indicator composition for application on a polymeric substrate |
| US9889222B2 (en) | 2011-11-09 | 2018-02-13 | Kimberly-Clark Worldwide, Inc. | Aqueous medium-sensitive coating compositions for triggered release of active ingredients and visual indication for wetness |
| US9585826B2 (en) | 2012-11-07 | 2017-03-07 | Kimberly-Clark Worldwide, Inc. | Triggerable compositions for two-stage, controlled release of active chemistry |
| US9119780B2 (en) | 2013-10-30 | 2015-09-01 | Kimberly-Clark Worldwide, Inc. | Triggerable compositions for two-stage, controlled release of proactive chemistry |
| BR112016009749A8 (pt) | 2013-11-13 | 2018-01-30 | Euro Celtique Sa | hidromorfona e naloxona para tratamento de dor e síndrome de disfunção intestinal opioide |
| CN104721141A (zh) * | 2013-12-18 | 2015-06-24 | 博瑞生物医药技术(苏州)有限公司 | 抗真菌药物固体分散体 |
| US11372041B2 (en) * | 2020-12-02 | 2022-06-28 | Guzik Technical Enterprises | Phase frequency response measurement method |
| GB2608645A (en) * | 2021-07-09 | 2023-01-11 | Reckitt Benckiser Health Ltd | Novel use of polymer combination |
| GB2625584A (en) * | 2022-12-21 | 2024-06-26 | Rb Health Us Llc | Novel composition |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0818154A (ja) * | 1994-07-04 | 1996-01-19 | Japan Aviation Electron Ind Ltd | ２波長半導体レーザ |
| CA2240161C (en) * | 1996-05-20 | 2005-05-24 | Janssen Pharmaceutica N.V. | Antifungal compositions with improved bioavailability |
| AU1511399A (en) * | 1997-12-31 | 1999-07-19 | Choongwae Pharma Corporation | Method and composition of an oral preparation of itraconazole |
| WO2001034119A2 (en) * | 1999-11-12 | 2001-05-17 | Abbott Laboratories | Inhibitors of crystallization in a solid dispersion |
| DE10038571A1 (de) * | 2000-08-03 | 2002-02-14 | Knoll Ag | Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen |
-
2003
- 2003-07-01 NZ NZ536975A patent/NZ536975A/en unknown
- 2003-07-01 US US10/518,987 patent/US7407670B2/en not_active Expired - Fee Related
- 2003-07-01 JP JP2004518649A patent/JP2005538973A/ja active Pending
- 2003-07-01 CA CA002489071A patent/CA2489071A1/en not_active Abandoned
- 2003-07-01 EP EP03762569A patent/EP1521571A1/en not_active Withdrawn
- 2003-07-01 WO PCT/EP2003/006999 patent/WO2004004683A1/en not_active Application Discontinuation
- 2003-07-01 CN CNB038158515A patent/CN1318019C/zh not_active Expired - Fee Related
- 2003-07-01 AU AU2003246351A patent/AU2003246351B2/en not_active Ceased
-
2005
- 2005-01-28 NO NO20050506A patent/NO20050506L/no not_active Application Discontinuation
-
2006
- 2006-01-09 HK HK06100333A patent/HK1080373A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003246351A1 (en) | 2004-01-23 |
| JP2005538973A (ja) | 2005-12-22 |
| EP1521571A1 (en) | 2005-04-13 |
| NZ536975A (en) | 2006-10-27 |
| AU2003246351B2 (en) | 2009-02-19 |
| CN1665483A (zh) | 2005-09-07 |
| CA2489071A1 (en) | 2004-01-15 |
| WO2004004683A1 (en) | 2004-01-15 |
| WO2004004683A8 (en) | 2004-11-25 |
| US20060062809A1 (en) | 2006-03-23 |
| HK1080373A1 (en) | 2006-04-28 |
| CN1318019C (zh) | 2007-05-30 |
| US7407670B2 (en) | 2008-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20050506L (no) | Fast dispersjon inneholdende to ulike polymermatrikser | |
| DE602004028023D1 (de) | Tacrolimus enthaltende feste dispersionen | |
| CY1109312T1 (el) | Μικροενκαψυλιωμενο σκευασμα φυτοφαρμακου | |
| TW200633716A (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
| DE50115609D1 (de) | Wässrige Dispersion wasserunlöslicher organischer UV-Filtersubstanzen | |
| CY1108766T1 (el) | Συνθεσεις και μεθοδοι για την προληψη ή την μειωση της αντοχης των εντομων στα εντομοκτονα | |
| MX2009004475A (es) | Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma. | |
| TW200621268A (en) | Antimicrobial copolymers and uses thereof | |
| NO20062798L (no) | Anvendelse av en vannholdig dispersjon av i det minste en bio-nedbrytbar polymer inneholdende i det minste et stabiliseringsmiddel for fremstilling av en vanndig filmdannende sammensetning | |
| BRPI0418330A (pt) | composições sólidas de drogas de solubilidade baixa e poloxámeros | |
| DK1853111T3 (da) | Fluegellokkemad | |
| WO2007067519A3 (en) | The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions | |
| WO2003105767A8 (en) | ANTIFUNGAL PARENTERAL PRODUCTS | |
| TNSN06293A1 (en) | Ophthalmic solution comprising sodium carboxymethylcellulose and hydroxypropylmethylcellulose | |
| CA2641347C (en) | Indazole-heteroaryl derivatives | |
| NZ588428A (en) | Oral and injectable formulations of the tetracycline compound 9-[(2,2-dimethyl-propylamino)-methyl]-minocycline | |
| EA201070806A1 (ru) | Состав медленного высвобождения на основе ассоциации гликогена и альгината | |
| DE60232271D1 (de) | Wässrige pharmazeutische formulierungen von wasserlöslichen prodrugs von propofol-verbindungen | |
| NO20073071L (no) | Benzotiazolformuleringer og anvendelse av disse | |
| EA200800203A1 (ru) | Замещенные изотопами ингибиторы протонного насоса | |
| WO2004044124A3 (en) | Identification of oligoadenylate synthetase-like genes | |
| AR034554A1 (es) | Un metodo para mejorar la distribucion de un ingrediente activo en un licor de curtido, una tableta o bloque para ser usado en dicho metodo, y el uso de dicha tableta o bloque en el curtido de cuero | |
| EA201000585A1 (ru) | Многочастичная матричная система, содержащая галантамин | |
| EP1680098A4 (en) | DELAYED RELEASE OF POSITIVELY-LOADED PHARMACOLOGICALLY EFFECTIVE MOLECULES FROM A POLYMER-CONTAINING MATRIX WITH POLARIZED OXYGENATOMES | |
| TNSN07438A1 (en) | Prolonged release formulation of active principles having a ph-dependent solubility |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |